Max Robotics — Global Service Robot Directory + US Certification

About

Cedars-Sinai Medical Center stands at the forefront of surgical robotics, artificial intelligence, and minimally invasive medicine, establishing itself as one of the most influential clinical research institutions in the world. Rooted in translational science that bridges laboratory discovery with patient care, Cedars-Sinai has built a remarkable portfolio of work that is reshaping how surgeons operate, how hospitals train, and how technology integrates into the operating room. The institution's contributions to robotic surgery span decades and disciplines. From pioneering work on robotic endoscopes in the late 1990s and early 2000s—including biomechanical modeling of the small intestine for autonomous locomotion—to landmark multi-institutional studies on robot-assisted cystectomy, lobectomy, esophagectomy, and mitral valve repair, Cedars-Sinai has consistently driven evidence-based adoption of surgical robotics. Their celebrated Three Hundred Robotic-Assisted Mitral Valve Repairs series demonstrated the institution's capacity to master and scale complex robotic cardiac procedures, while multi-database comparative studies have provided the field with rigorous outcome benchmarks. Equally impressive is Cedars-Sinai's leadership in the human factors of robotic surgery—examining safety, teamwork dynamics, and learning curves in real clinical environments. This systems-level thinking extends to AI integration in surgery, with highly cited 2024 work positioning the institution as a thought leader in next-generation operative intelligence. Wearable technology for postoperative monitoring, remote cardiac ablation navigation, and participation in major consortia like the LINCS NIH program further illustrate the breadth of Cedars-Sinai's research ecosystem. With hundreds of citations across these domains, the institution offers prospective students and collaborators an unparalleled environment where clinical excellence and technological innovation converge.